Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14151-14200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04221945
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
PHASE3
Active, not recruiting
1,060 participants
Started: May 12, 2020 · Completed: Jan 17, 2026
1 condition
3 sponsors
176 locations
NCT04384770
CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study
N/A
Active, not recruiting
179 participants
Started: May 12, 2020 · Completed: Apr 1, 2027
1 condition
1 sponsor
1 location
NCT04447222
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
N/A
Active, not recruiting
1,242 participants
Started: May 12, 2020 · Completed: Jul 30, 2026
2 conditions
2 sponsors
1 location
NCT04212416
Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease
PHASE1
Active, not recruiting
18 participants
Started: May 12, 2020 · Completed: Jun 22, 2026
2 conditions
2 sponsors
1 location
NCT04267887
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
PHASE2
Active, not recruiting
7 participants
Started: May 11, 2020 · Completed: Jan 1, 2030
3 conditions
3 sponsors
1 location
NCT04126070
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
PHASE2
Active, not recruiting
60 participants
Started: May 11, 2020 · Completed: Dec 30, 2025
3 conditions
2 sponsors
6 locations
NCT04070183
POST Facilitation for Community Dwelling Older Adults (POST-RCT)
NA
Active, not recruiting
778 participants
Started: May 11, 2020 · Completed: Oct 31, 2025
4 conditions
7 sponsors
3 locations
NCT04373902
Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia
NA
Active, not recruiting
140 participants
Started: May 11, 2020 · Completed: Jul 1, 2026
3 conditions
1 sponsor
9 locations
NCT04392505
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
PHASE2
Active, not recruiting
100 participants
Started: May 11, 2020 · Completed: May 1, 2033
5 conditions
2 sponsors
10 locations
NCT06178692
Validation Study of a Serum-miRNA Signature in Glioma Patients.
N/A
Active, not recruiting
30 participants
Started: May 10, 2020 · Completed: May 10, 2024
1 condition
5 sponsors
1 location
NCT04370821
COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers
N/A
Active, not recruiting
2,600 participants
Started: May 9, 2020 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT04322006
A Phase I/II Study of TJ004309 for Advanced Solid Tumor
PHASE1/PHASE2
Active, not recruiting
376 participants
Started: May 9, 2020 · Completed: Dec 30, 2025
1 condition
1 sponsor
23 locations
NCT04246047
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
PHASE3
Active, not recruiting
494 participants
Started: May 7, 2020 · Completed: Jun 19, 2026
1 condition
1 sponsor
144 locations
NCT04384146
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
PHASE1
Active, not recruiting
41 participants
Started: May 7, 2020 · Completed: May 31, 2026
1 condition
1 sponsor
7 locations
NCT04092270
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
PHASE1
Active, not recruiting
54 participants
Started: May 7, 2020 · Completed: Jun 1, 2026
29 conditions
1 sponsor
11 locations
NCT04431076
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
N/A
Active, not recruiting
560 participants
Started: May 7, 2020 · Completed: Jun 30, 2024
6 conditions
1 sponsor
1 location
NCT04357925
Quality of Life in Prostate Cancer Patients
N/A
Active, not recruiting
304 participants
Started: May 6, 2020 · Completed: May 6, 2027
1 condition
2 sponsors
1 location
NCT04605679
Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients
NA
Active, not recruiting
31 participants
Started: May 6, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04221490
2019-06 TRISCEND Study
NA
Active, not recruiting
228 participants
Started: May 6, 2020 · Completed: Jan 31, 2029
3 conditions
1 sponsor
20 locations
NCT04269200
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
PHASE3
Active, not recruiting
813 participants
Started: May 5, 2020 · Completed: Apr 1, 2027
1 condition
3 sponsors
201 locations
NCT04402125
Reducing Stroke Risk in African-American Men
NA
Active, not recruiting
160 participants
Started: May 5, 2020 · Completed: Nov 30, 2025
2 conditions
2 sponsors
1 location
NCT04372251
Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach
NA
Active, not recruiting
70 participants
Started: May 5, 2020 · Completed: Dec 31, 2031
1 condition
4 sponsors
5 locations
NCT04389827
Global Kidney Patient Trials Network
N/A
Active, not recruiting
6,000 participants
Started: May 5, 2020 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT04303858
A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
PHASE1
Active, not recruiting
189 participants
Started: May 4, 2020 · Completed: Aug 15, 2026
1 condition
1 sponsor
13 locations
NCT04300244
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
PHASE2
Active, not recruiting
118 participants
Started: May 4, 2020 · Completed: Mar 15, 2027
7 conditions
4 sponsors
7 locations
NCT04223596
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
PHASE2
Active, not recruiting
33 participants
Started: May 4, 2020 · Completed: Dec 30, 2026
4 conditions
1 sponsor
15 locations
NCT04568369
Treatment of Post-concussion Syndrome With TMS: Using FNIRS as a Biomarker of Response
NA
Active, not recruiting
91 participants
Started: May 2, 2020 · Completed: Mar 31, 2024
6 conditions
1 sponsor
1 location
NCT04394390
Should Ranges of Vitamin D be Redefined to Prevent or Treat Viral Infections?
N/A
Active, not recruiting
1,100 participants
Started: May 1, 2020 · Completed: Apr 30, 2025
2 conditions
1 sponsor
1 location
NCT03930199
Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users
NA
Active, not recruiting
66 participants
Started: May 1, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT04380311
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
NA
Active, not recruiting
15 participants
Started: May 1, 2020 · Completed: Apr 30, 2025
1 condition
2 sponsors
2 locations
NCT04248192
Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
PHASE1
Active, not recruiting
8 participants
Started: May 1, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05691296
The Monitoring and Intervention of Refractive Changes in Children and Teenagers in Tianjin
NA
Active, not recruiting
4,000 participants
Started: May 1, 2020 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04380064
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy
NA
Active, not recruiting
200 participants
Started: May 1, 2020 · Completed: Feb 1, 2025
1 condition
1 sponsor
1 location
NCT04374461
A Study of N-acetylcysteine in Patients With COVID-19 Infection
PHASE2
Active, not recruiting
48 participants
Started: May 1, 2020 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05718336
Atrial Fibrillation Trial To Eliminate Risk-factors
N/A
Active, not recruiting
1,000 participants
Started: May 1, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04398459
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
PHASE2
Active, not recruiting
18 participants
Started: May 1, 2020 · Completed: Jun 30, 2025
1 condition
1 sponsor
3 locations
NCT04143646
New Technologies for Intensive Prevention Programs - NET-IPP
NA
Active, not recruiting
864 participants
Started: May 1, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04009005
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
NA
Active, not recruiting
44 participants
Started: May 1, 2020 · Completed: Sep 1, 2027
2 conditions
1 sponsor
1 location
NCT04459052
FDOPA PET and Nutritional Support in Parkinson's Disease
PHASE2
Active, not recruiting
50 participants
Started: Apr 30, 2020 · Completed: Jan 8, 2027
2 conditions
1 sponsor
1 location
NCT04404894
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
N/A
Active, not recruiting
500 participants
Started: Apr 30, 2020 · Completed: Nov 30, 2029
1 condition
1 sponsor
7 locations
NCT04157101
Health Coaching for Chronic Multisymptom Illness
NA
Active, not recruiting
260 participants
Started: Apr 30, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04033081
Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®
PHASE4
Active, not recruiting
100 participants
Started: Apr 30, 2020 · Completed: Apr 30, 2030
1 condition
1 sponsor
1 location
NCT04241276
A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer
PHASE2
Active, not recruiting
170 participants
Started: Apr 30, 2020 · Completed: Feb 28, 2029
1 condition
3 sponsors
1 location
NCT04163419
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
PHASE2
Active, not recruiting
9 participants
Started: Apr 30, 2020 · Completed: Sep 30, 2024
2 conditions
2 sponsors
1 location
NCT04092283
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
660 participants
Started: Apr 29, 2020 · Completed: Dec 31, 2028
6 conditions
1 sponsor
835 locations
NCT04396145
The Effects of Chronic Otitis Surgery on SVV
N/A
Active, not recruiting
30 participants
Started: Apr 29, 2020 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT03932331
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
PHASE1/PHASE2
Active, not recruiting
105 participants
Started: Apr 29, 2020 · Completed: Jun 24, 2026
3 conditions
1 sponsor
23 locations
NCT03978988
Thrombectomy In TANdem Occlusion
NA
Active, not recruiting
432 participants
Started: Apr 29, 2020 · Completed: Mar 6, 2026
4 conditions
1 sponsor
1 location
NCT04286100
Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
N/A
Active, not recruiting
60 participants
Started: Apr 29, 2020 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT04368013
Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial
N/A
Active, not recruiting
550 participants
Started: Apr 28, 2020 · Completed: Apr 14, 2026
1 condition
6 sponsors
4 locations
Previous
1
More pages
281
282
283
284
285
286
287
More pages
431
Next